US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist
  • 48.690
  • -0.160-0.33%
Close Apr 19 16:00 ET
  • 49.500
  • +0.810+1.66%
Post 19:19 ET
2.52BMarket Cap-36886P/E (TTM)

Janux Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-6.14%8.08M
-13.50%2.46M
38.83%2.52M
-55.31%1.06M
28.89%2.05M
136.79%8.61M
76.05%2.85M
56.43%1.81M
390.66%2.37M
318.16%1.59M
Operating revenue
-6.14%8.08M
-13.50%2.46M
38.83%2.52M
-55.31%1.06M
28.89%2.05M
136.79%8.61M
76.05%2.85M
56.43%1.81M
390.66%2.37M
318.16%1.59M
Cost of revenue
Gross profit
Operating expense
7.08%81.06M
-11.90%18.6M
-7.59%18.33M
11.10%21.81M
47.57%22.33M
107.03%75.7M
39.75%21.11M
64.44%19.84M
191.45%19.63M
467.98%15.13M
Selling and administrative expenses
17.42%26.14M
11.98%6.36M
5.58%6.44M
24.21%6.88M
30.67%6.46M
115.53%22.26M
44.20%5.68M
66.79%6.1M
177.42%5.54M
569.42%4.95M
-General and administrative expense
17.42%26.14M
11.98%6.36M
5.58%6.44M
24.21%6.88M
30.67%6.46M
115.53%22.26M
44.20%5.68M
66.79%6.1M
177.42%5.54M
569.42%4.95M
Research and development costs
2.77%54.92M
-20.69%12.24M
-13.43%11.89M
5.95%14.92M
55.78%15.87M
103.69%53.44M
38.19%15.43M
63.42%13.74M
197.36%14.09M
429.04%10.18M
Operating profit
-8.78%-72.98M
11.66%-16.14M
12.26%-15.81M
-20.20%-20.75M
-49.76%-20.28M
-103.74%-67.09M
-35.40%-18.27M
-65.29%-18.02M
-176.09%-17.26M
-492.91%-13.54M
Net non-operating interest income expense
264.24%14.69M
98.96%4.38M
220.14%4.25M
768.63%3.24M
2,037.88%2.82M
1,468.87%4.03M
2,874.32%2.2M
867.88%1.33M
710.87%373K
132K
Non-operating interest income
264.24%14.69M
98.96%4.38M
220.14%4.25M
768.63%3.24M
2,037.88%2.82M
1,468.87%4.03M
2,874.32%2.2M
867.88%1.33M
710.87%373K
--132K
Other net income (expense)
Income before tax
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
-55.08%-16.7M
-172.12%-16.89M
-487.13%-13.41M
Income tax
Net income
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
-55.08%-16.7M
-172.12%-16.89M
-487.13%-13.41M
Net income continuous Operations
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
-55.08%-16.7M
-172.12%-16.89M
-487.13%-13.41M
Minority interest income
Net income attributable to the parent company
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
-55.08%-16.7M
-172.12%-16.89M
-487.13%-13.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
-55.08%-16.7M
-172.12%-16.89M
-487.13%-13.41M
Basic earnings per share
13.16%-1.32
38.46%-0.24
37.50%-0.25
-2.44%-0.42
-31.25%-0.42
-9.35%-1.52
-18.18%-0.39
-53.85%-0.4
33.87%-0.41
-459.04%-0.32
Diluted earnings per share
13.16%-1.32
38.46%-0.24
37.50%-0.25
-2.44%-0.42
-31.25%-0.42
-9.35%-1.52
-18.18%-0.39
-53.85%-0.4
33.87%-0.41
-459.04%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -6.14%8.08M-13.50%2.46M38.83%2.52M-55.31%1.06M28.89%2.05M136.79%8.61M76.05%2.85M56.43%1.81M390.66%2.37M318.16%1.59M
Operating revenue -6.14%8.08M-13.50%2.46M38.83%2.52M-55.31%1.06M28.89%2.05M136.79%8.61M76.05%2.85M56.43%1.81M390.66%2.37M318.16%1.59M
Cost of revenue
Gross profit
Operating expense 7.08%81.06M-11.90%18.6M-7.59%18.33M11.10%21.81M47.57%22.33M107.03%75.7M39.75%21.11M64.44%19.84M191.45%19.63M467.98%15.13M
Selling and administrative expenses 17.42%26.14M11.98%6.36M5.58%6.44M24.21%6.88M30.67%6.46M115.53%22.26M44.20%5.68M66.79%6.1M177.42%5.54M569.42%4.95M
-General and administrative expense 17.42%26.14M11.98%6.36M5.58%6.44M24.21%6.88M30.67%6.46M115.53%22.26M44.20%5.68M66.79%6.1M177.42%5.54M569.42%4.95M
Research and development costs 2.77%54.92M-20.69%12.24M-13.43%11.89M5.95%14.92M55.78%15.87M103.69%53.44M38.19%15.43M63.42%13.74M197.36%14.09M429.04%10.18M
Operating profit -8.78%-72.98M11.66%-16.14M12.26%-15.81M-20.20%-20.75M-49.76%-20.28M-103.74%-67.09M-35.40%-18.27M-65.29%-18.02M-176.09%-17.26M-492.91%-13.54M
Net non-operating interest income expense 264.24%14.69M98.96%4.38M220.14%4.25M768.63%3.24M2,037.88%2.82M1,468.87%4.03M2,874.32%2.2M867.88%1.33M710.87%373K132K
Non-operating interest income 264.24%14.69M98.96%4.38M220.14%4.25M768.63%3.24M2,037.88%2.82M1,468.87%4.03M2,874.32%2.2M867.88%1.33M710.87%373K--132K
Other net income (expense)
Income before tax 7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M-55.08%-16.7M-172.12%-16.89M-487.13%-13.41M
Income tax
Net income 7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M-55.08%-16.7M-172.12%-16.89M-487.13%-13.41M
Net income continuous Operations 7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M-55.08%-16.7M-172.12%-16.89M-487.13%-13.41M
Minority interest income
Net income attributable to the parent company 7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M-55.08%-16.7M-172.12%-16.89M-487.13%-13.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M-55.08%-16.7M-172.12%-16.89M-487.13%-13.41M
Basic earnings per share 13.16%-1.3238.46%-0.2437.50%-0.25-2.44%-0.42-31.25%-0.42-9.35%-1.52-18.18%-0.39-53.85%-0.433.87%-0.41-459.04%-0.32
Diluted earnings per share 13.16%-1.3238.46%-0.2437.50%-0.25-2.44%-0.42-31.25%-0.42-9.35%-1.52-18.18%-0.39-53.85%-0.433.87%-0.41-459.04%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg